<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39398386</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-7007</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Diabetes, metabolic syndrome and obesity : targets and therapy</Title><ISOAbbreviation>Diabetes Metab Syndr Obes</ISOAbbreviation></Journal><ArticleTitle>The Bidirectional Association Between Metabolic Syndrome and Long-COVID-19.</ArticleTitle><Pagination><StartPage>3697</StartPage><EndPage>3710</EndPage><MedlinePgn>3697-3710</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/DMSO.S484733</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The rapid global spread of a new coronavirus disease known as COVID-19&#xa0;has led to a significant increase in mortality rates, resulting in an unprecedented worldwide pandemic.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The impact of COVID-19, particularly its long-term effects, has also had a profound effect on the health and well-being of individuals.Metabolic syndrome increases the risk of heart and brain diseases, presenting a significant danger to human well-being.</AbstractText><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">The prognosis of long COVID and the progression of metabolic syndrome interact with each other, but there is currently a lack of systematic reports.In this paper, the pathogenesis, related treatment and prognosis of long COVID and metabolic syndrome are systematically reviewed.</AbstractText><CopyrightInformation>&#xa9; 2024 Liu and Lou.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yanfen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Endocrinology at Zhejiang University School of Medicine, Jinhua Hospital, Jinhua, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lou</LastName><ForeName>Xueyong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Endocrinology at Zhejiang University School of Medicine, Jinhua Hospital, Jinhua, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Diabetes Metab Syndr Obes</MedlineTA><NlmUniqueID>101515585</NlmUniqueID><ISSNLinking>1178-7007</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiovascular disease</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Metabolic syndrome</Keyword><Keyword MajorTopicYN="N">drugs</Keyword><Keyword MajorTopicYN="N">pathway</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39398386</ArticleId><ArticleId IdType="pmc">PMC11471063</ArticleId><ArticleId IdType="doi">10.2147/DMSO.S484733</ArticleId><ArticleId IdType="pii">484733</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): a Review. JAMA. 2020;324(8):782&#x2013;793. doi:10.1001/jama.2020.12839</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054&#x2013;1062. doi:10.1016/S0140-6736(20)30566-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. doi:10.1016/j.ijantimicag.2020.105924</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.105924</ArticleId><ArticleId IdType="pmc">PMC7127800</ArticleId><ArticleId IdType="pubmed">32081636</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033&#x2013;2040. doi:10.1182/blood.2020006000</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020006000</ArticleId><ArticleId IdType="pmc">PMC7273827</ArticleId><ArticleId IdType="pubmed">32339221</ArticleId></ArticleIdList></Reference><Reference><Citation>Siso-Almirall A, Kostov B, Mas-Heredia M, et al. Prognostic factors in Spanish COVID-19 patients: a case series from Barcelona. PLoS One. 2020;15(8):e0237960. doi:10.1371/journal.pone.0237960</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0237960</ArticleId><ArticleId IdType="pmc">PMC7444503</ArticleId><ArticleId IdType="pubmed">32822413</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. WHO COVID-19 Dashboard
Available from: https://covid19.who.int/?mapFilter=cas. Acessed September
26, 2024.</Citation></Reference><Reference><Citation>COVID-19 rapid guideline: managing the long-term effects of COVID-19. National Institute for Health and Care Excellence: Clinical Guidelines; 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Baral R, White M, Vassiliou VS. Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients. Curr Atheroscler Rep. 2020;22(10):61. doi:10.1007/s11883-020-00880-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11883-020-00880-6</ArticleId><ArticleId IdType="pmc">PMC7443394</ArticleId><ArticleId IdType="pubmed">32830286</ArticleId></ArticleIdList></Reference><Reference><Citation>Panagides V, Vincent F, Weizman O, et al. History of heart failure in patients with coronavirus disease 2019: insights from a French registry. Arch Cardiovasc Dis. 2021;114(5):415&#x2013;425. doi:10.1016/j.acvd.2021.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acvd.2021.04.003</ArticleId><ArticleId IdType="pmc">PMC8141712</ArticleId><ArticleId IdType="pubmed">34099379</ArticleId></ArticleIdList></Reference><Reference><Citation>De Giorgi C, De Luca F, Di Vito M, Lamberti F. Modulation of expression at the level of splicing of cut-1 RNA in the infective second-stage juvenile of the plant parasitic nematode Meloidogyne artiellia. Mol Gen Genet. 1997;253(5):589&#x2013;598. doi:10.1007/s004380050361</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004380050361</ArticleId><ArticleId IdType="pubmed">9065692</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881&#x2013;895e820. doi:10.1016/j.cell.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323(20):2052&#x2013;2059. doi:10.1001/jama.2020.6775</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6775</ArticleId><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: a Meta-Analysis and Systematic Review. J Infect Dis. 2022;226(9):1593&#x2013;1607. doi:10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;(38):101019. doi:10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232. doi:10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. Condition WHOCCDWGoP-C-. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;e107. doi:10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarafidis PA, Nilsson PM. The metabolic syndrome: a glance at its history. J Hypertens. 2006;24(4):621&#x2013;626. doi:10.1097/01.hjh.0000217840.26971.b6</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.hjh.0000217840.26971.b6</ArticleId><ArticleId IdType="pubmed">16531786</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539&#x2013;553. doi:10.1002/(SICI)1096-9136(199807)15:7</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9136(199807)15:7</ArticleId><ArticleId IdType="pubmed">9686693</ArticleId></ArticleIdList></Reference><Reference><Citation>Julibert A, Bibiloni MDM, Mateos D, Angullo E, Tur JA. Dietary Fat Intake and Metabolic Syndrome in Older Adults. Nutrients. 2019;11(8). doi:10.3390/nu11081901</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11081901</ArticleId><ArticleId IdType="pmc">PMC6723812</ArticleId><ArticleId IdType="pubmed">31416272</ArticleId></ArticleIdList></Reference><Reference><Citation>Cano-Ibanez N, Gea A, Martinez-Gonzalez MA, et al. Dietary Diversity and Nutritional Adequacy among an Older Spanish Population with Metabolic Syndrome in the PREDIMED-Plus Study: a Cross-Sectional Analysis. Nutrients. 2019;11(5):958. doi:10.3390/nu11050958</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11050958</ArticleId><ArticleId IdType="pmc">PMC6567048</ArticleId><ArticleId IdType="pubmed">31035497</ArticleId></ArticleIdList></Reference><Reference><Citation>Garralda-Del-Villar M, Carlos-Chilleron S, Diaz-Gutierrez J, et al. Healthy Lifestyle and Incidence of Metabolic Syndrome in the SUN Cohort. Nutrients. 2018;11(1). doi:10.3390/nu11010065</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11010065</ArticleId><ArticleId IdType="pmc">PMC6357191</ArticleId><ArticleId IdType="pubmed">30598006</ArticleId></ArticleIdList></Reference><Reference><Citation>Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018;20(2):12. doi:10.1007/s11906-018-0812-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11906-018-0812-z</ArticleId><ArticleId IdType="pmc">PMC5866840</ArticleId><ArticleId IdType="pubmed">29480368</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda PJ, DeFronzo RA, Califf RM, Guyton JR. Metabolic syndrome: definition, pathophysiology, and mechanisms. Am Heart J. 2005;149(1):33&#x2013;45. doi:10.1016/j.ahj.2004.07.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2004.07.013</ArticleId><ArticleId IdType="pubmed">15660032</ArticleId></ArticleIdList></Reference><Reference><Citation>Association AH
What Is Metabolic Sydrome?
Available from: https://www.heart.org/en/health-topics/metabolicsyndrome/about-metabolic-syndrome. Acessed September
26, 2024.</Citation></Reference><Reference><Citation>Expert Panel on Detection E. Treatment of High Blood Cholesterol in A. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486&#x2013;2497. doi:10.1001/jama.285.19.2486</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.285.19.2486</ArticleId><ArticleId IdType="pubmed">11368702</ArticleId></ArticleIdList></Reference><Reference><Citation>Grundy SM, Cleeman JI, Daniels SR, et al. Spertus JA, Costa F, American Heart A, National Heart L, Blood I. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735&#x2013;2752. doi:10.1161/CIRCULATIONAHA.105.169404</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.169404</ArticleId><ArticleId IdType="pubmed">16157765</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons RK, Alberti KG, Gale EA, et al. The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia. 2010;53(4):600&#x2013;605. doi:10.1007/s00125-009-1620-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-009-1620-4</ArticleId><ArticleId IdType="pubmed">20012011</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Townsend L, Morrin H, et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. 2021;19(10):2546&#x2013;2553. doi:10.1111/jth.15490</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie SA, Connell JM. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis. 2007;17(4):319&#x2013;326. doi:10.1016/j.numecd.2006.07.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.numecd.2006.07.005</ArticleId><ArticleId IdType="pubmed">17110092</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (2021) Post COVID conditions
Available from: https://www.cdc.gov/coronavirus/2019-ncov/long-term-efects/index.html. Acessed September
26, 2024.</Citation></Reference><Reference><Citation>Excellence NIfHa C
COVID-19 rapid guideline: managing the long-term effects of COVID-19
Available from: https://www.nice.org.uk/guidance/ng188. Acessed September
26, 2024.</Citation></Reference><Reference><Citation>condition CdCpC. Coronavirus disease (COVID 19): post COVID 19 condition
Available from: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition. Acessed September
26, 2024.</Citation></Reference><Reference><Citation>Service NHNHS (2022) long term effect of coronavirus (long COVID
Available from: https://www.nhs.uk/conditions/coronavirus-covid-19/long-term-efects-of-coronavirus-long-covid/. Acessed September
26, 2024.</Citation></Reference><Reference><Citation>Guideline C-R
Managing the Longterm Effects of COVID-19. National Institute for Health and Care Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN) and Royal College of General Practitioners (RCGP)
Available from: https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-. Acessed September
26, 2024.</Citation></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv. 2021. doi:10.1101/2021.01.27.21250617</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.27.21250617</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Kuraishy HM, Al-Gareeb AI, Alblihed M, Guerreiro SG, Cruz-Martins N, Batiha GE. COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus. Front Cardiovasc Med. 2021(8):644095. doi:10.3389/fcvm.2021.644095</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.644095</ArticleId><ArticleId IdType="pmc">PMC8189260</ArticleId><ArticleId IdType="pubmed">34124187</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyerstedt S, Casaro EB, Rangel EB. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021;40(5):905&#x2013;919. doi:10.1007/s10096-020-04138-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-04138-6</ArticleId><ArticleId IdType="pmc">PMC7778857</ArticleId><ArticleId IdType="pubmed">33389262</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima-Martinez MM, Carrera Boada C, Madera-Silva MD, Marin W, Contreras M. COVID-19 and diabetes: a bidirectional relationship. Clin Investig Arterioscler. 2021;33(3):151&#x2013;157. doi:10.1016/j.arteri.2020.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arteri.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7598432</ArticleId><ArticleId IdType="pubmed">33303218</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasbinder A, Anderson E, Shadid H, et al. Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19. Diabetes Care. 2022;45(3):692&#x2013;700. doi:10.2337/dc21-2102</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc21-2102</ArticleId><ArticleId IdType="pmc">PMC8918261</ArticleId><ArticleId IdType="pubmed">35045184</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao S, Yang Q, Pan R, Yu X, Chen Y. Interaction of Severe Acute Respiratory Syndrome Coronavirus 2 and Diabetes. Front Endocrinol (Lausanne). 2021;(12):731974. doi:10.3389/fendo.2021.731974</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.731974</ArticleId><ArticleId IdType="pmc">PMC8527093</ArticleId><ArticleId IdType="pubmed">34690930</ArticleId></ArticleIdList></Reference><Reference><Citation>Unnikrishnan R, Misra A. Diabetes and COVID19: a bidirectional relationship. Nutr Diabetes. 2021;11(1):21. doi:10.1038/s41387-021-00163-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41387-021-00163-2</ArticleId><ArticleId IdType="pmc">PMC8223528</ArticleId><ArticleId IdType="pubmed">34168110</ArticleId></ArticleIdList></Reference><Reference><Citation>Misra A, Ghosh A, Gupta R. Heterogeneity in presentation of hyperglycaemia during COVID-19 pandemic: a proposed classification. Diabetes Metab Syndr. 2021;15(1):403&#x2013;406. doi:10.1016/j.dsx.2021.01.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.01.018</ArticleId><ArticleId IdType="pmc">PMC7847699</ArticleId><ArticleId IdType="pubmed">33588198</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh A, Anjana RM, Shanthi Rani CS, et al. Glycemic parameters in patients with new-onset diabetes during COVID-19 pandemic are more severe than in patients with new-onset diabetes before the pandemic: NOD COVID India Study. Diabetes Metab Syndr. 2021;15(1):215&#x2013;220. doi:10.1016/j.dsx.2020.12.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.12.033</ArticleId><ArticleId IdType="pmc">PMC7771314</ArticleId><ArticleId IdType="pubmed">33450530</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021;15(4):102146. doi:10.1016/j.dsx.2021.05.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.05.019</ArticleId><ArticleId IdType="pmc">PMC8137376</ArticleId><ArticleId IdType="pubmed">34192610</ArticleId></ArticleIdList></Reference><Reference><Citation>Wadman M. Why obesity worsens COVID-19. Science. 2020;369(6509):1280&#x2013;1281. doi:10.1126/science.369.6509.1280</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.369.6509.1280</ArticleId><ArticleId IdType="pubmed">32913079</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford H. How obesity could create problems for a COVID vaccine. Nature. 2020;586(7830):488&#x2013;489. doi:10.1038/d41586-020-02946-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02946-6</ArticleId><ArticleId IdType="pubmed">33082543</ArticleId></ArticleIdList></Reference><Reference><Citation>CD. Centers for Disease Control and Prevention
Available from: https://www.cdc.gov/media/releases/2020/p0625-update-expands-covid-19.html. Acessed September
26, 2024.</Citation></Reference><Reference><Citation>Talbot HK, Coleman LA, Crimin K, et al. Association between obesity and vulnerability and serologic response to influenza vaccination in older adults. Vaccine. 2012;30(26):3937&#x2013;3943. doi:10.1016/j.vaccine.2012.03.071</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2012.03.071</ArticleId><ArticleId IdType="pmc">PMC3770527</ArticleId><ArticleId IdType="pubmed">22484350</ArticleId></ArticleIdList></Reference><Reference><Citation>Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MA Jr. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci U S A. 1986;83(12):4533&#x2013;4537. doi:10.1073/pnas.83.12.4533</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.83.12.4533</ArticleId><ArticleId IdType="pmc">PMC323768</ArticleId><ArticleId IdType="pubmed">3487091</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi Y, Bowman JW, Jung JU. Autophagy during viral infection - a double-edged sword. Nat Rev Microbiol. 2018;16(6):341&#x2013;354. doi:10.1038/s41579-018-0003-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0003-6</ArticleId><ArticleId IdType="pmc">PMC6907743</ArticleId><ArticleId IdType="pubmed">29556036</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Zhang H, Zhou M, et al. Prognosis of COVID-19 in patients with vein thrombosis: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2020;24(19):10279&#x2013;10285. doi:10.26355/eurrev_202010_23252</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202010_23252</ArticleId><ArticleId IdType="pubmed">33090439</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimobayashi M, Albert V, Woelnerhanssen B, et al. Insulin resistance causes inflammation in adipose tissue. J Clin Invest. 2018;128(4):1538&#x2013;1550. doi:10.1172/JCI96139</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI96139</ArticleId><ArticleId IdType="pmc">PMC5873875</ArticleId><ArticleId IdType="pubmed">29528335</ArticleId></ArticleIdList></Reference><Reference><Citation>Zammit C, Liddicoat H, Moonsie I, Makker H. Obesity and respiratory diseases. Int J Gen Med. 2010;3:335&#x2013;343. doi:10.2147/IJGM.S11926</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S11926</ArticleId><ArticleId IdType="pmc">PMC2990395</ArticleId><ArticleId IdType="pubmed">21116339</ArticleId></ArticleIdList></Reference><Reference><Citation>Popkin BM, Du S, Green WD, et al. Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships. Obes Rev. 2020;21(11):e13128. doi:10.1111/obr.13128</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/obr.13128</ArticleId><ArticleId IdType="pmc">PMC7461480</ArticleId><ArticleId IdType="pubmed">32845580</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, Wang Y. The Clinical Characteristics and Risk Factors of Severe COVID-19. Gerontology. 2021;67(3):255&#x2013;266. doi:10.1159/000513400</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000513400</ArticleId><ArticleId IdType="pmc">PMC7900480</ArticleId><ArticleId IdType="pubmed">33406518</ArticleId></ArticleIdList></Reference><Reference><Citation>Twig G, Geva N, Levine H, et al. Body mass index and infectious disease mortality in midlife in a cohort of 2.3 million adolescents. Int J Obes (Lond). 2018;42(4):801&#x2013;807. doi:10.1038/ijo.2017.263</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ijo.2017.263</ArticleId><ArticleId IdType="pubmed">29081504</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng YY, Ma YT, Zhang JY. Reply to: &#x2018;Interaction between RAAS inhibitors and ACE2 in the context of COVID-19&#x2019;. Nat Rev Cardiol. 2020;17(5):313&#x2013;314. doi:10.1038/s41569-020-0369-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0369-9</ArticleId><ArticleId IdType="pmc">PMC7104711</ArticleId><ArticleId IdType="pubmed">32231330</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259&#x2013;260. doi:10.1038/s41569-020-0360-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0360-5</ArticleId><ArticleId IdType="pmc">PMC7095524</ArticleId><ArticleId IdType="pubmed">32139904</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghili SMM, Ebrahimpur M, Arjmand B, et al. Obesity in COVID-19 era, implications for mechanisms, comorbidities, and prognosis: a review and meta-analysis. Int J Obes (Lond). 2021;45(5):998&#x2013;1016. doi:10.1038/s41366-021-00776-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-021-00776-8</ArticleId><ArticleId IdType="pmc">PMC7909378</ArticleId><ArticleId IdType="pubmed">33637951</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle D, JS O, Sharif K, Emery P, Bridgewood C. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2020;2(7):e437&#x2013;e445. doi:10.1016/S2665-9913(20)30121-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30121-1</ArticleId><ArticleId IdType="pmc">PMC7252093</ArticleId><ArticleId IdType="pubmed">32835247</ArticleId></ArticleIdList></Reference><Reference><Citation>Verrijken A, Francque S, Mertens I, et al. Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 2014;59(1):121&#x2013;129. doi:10.1002/hep.26510</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.26510</ArticleId><ArticleId IdType="pubmed">24375485</ArticleId></ArticleIdList></Reference><Reference><Citation>Gazzaruso C, Paolozzi E, Valenti C, et al. Association between antithrombin and mortality in patients with COVID-19. A possible link with obesity. Nutr Metab Cardiovasc Dis. 2020;30(11):1914&#x2013;1919. doi:10.1016/j.numecd.2020.07.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.numecd.2020.07.040</ArticleId><ArticleId IdType="pmc">PMC7386389</ArticleId><ArticleId IdType="pubmed">32907762</ArticleId></ArticleIdList></Reference><Reference><Citation>Zisman A, Peroni OD, Abel ED, et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med. 2000;6(8):924&#x2013;928. doi:10.1038/78693</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/78693</ArticleId><ArticleId IdType="pubmed">10932232</ArticleId></ArticleIdList></Reference><Reference><Citation>Anker SD, Coats AJ, Morley JE, et al. Muscle wasting disease: a proposal for a new disease classification. J Cachexia Sarcopenia Muscle. 2014;5(1):1&#x2013;3. doi:10.1007/s13539-014-0135-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13539-014-0135-0</ArticleId><ArticleId IdType="pmc">PMC3953318</ArticleId><ArticleId IdType="pubmed">24595459</ArticleId></ArticleIdList></Reference><Reference><Citation>Tleyjeh IM, Saddik B, AlSwaidan N, et al. Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: a cohort study with 4 months median follow-up. PLoS One. 2021;16(12):e0260568. doi:10.1371/journal.pone.0260568</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0260568</ArticleId><ArticleId IdType="pmc">PMC8651136</ArticleId><ArticleId IdType="pubmed">34874962</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuin M, Rigatelli G, Zuliani G, Rigatelli A, Mazza A, Roncon L. Arterial hypertension and risk of death in patients with COVID-19 infection: systematic review and meta-analysis. J Infect. 2020;81(1):e84&#x2013;e86. doi:10.1016/j.jinf.2020.03.059</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.03.059</ArticleId><ArticleId IdType="pmc">PMC7151373</ArticleId><ArticleId IdType="pubmed">32283158</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhalla V, Blish CA, South AM. A historical perspective on ACE2 in the COVID-19 era. J Hum Hypertens. 2021;35(10):935&#x2013;939. doi:10.1038/s41371-020-00459-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41371-020-00459-3</ArticleId><ArticleId IdType="pmc">PMC7735396</ArticleId><ArticleId IdType="pubmed">33318644</ArticleId></ArticleIdList></Reference><Reference><Citation>Azevedo RB, Botelho BG, Hollanda JVG, et al. Covid-19 and the cardiovascular system: a comprehensive review. J Hum Hypertens. 2021;35(1):4&#x2013;11. doi:10.1038/s41371-020-0387-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41371-020-0387-4</ArticleId><ArticleId IdType="pmc">PMC7384729</ArticleId><ArticleId IdType="pubmed">32719447</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata S, Kobayashi K, Tanaka M, et al. COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19. Hypertens Res. 2023;46(3):589&#x2013;600. doi:10.1038/s41440-022-01134-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-022-01134-5</ArticleId><ArticleId IdType="pmc">PMC9780104</ArticleId><ArticleId IdType="pubmed">36550205</ArticleId></ArticleIdList></Reference><Reference><Citation>Ternushchak TM, Tovt-Korshynska MI, Varvarynets AV. Ambulatory Blood Pressure Variability in Young Adults with Long-Covid Syndrome. Wiad Lek. 2022;75(10):2481&#x2013;2485. doi:10.36740/WLek202210131</Citation><ArticleIdList><ArticleId IdType="doi">10.36740/WLek202210131</ArticleId><ArticleId IdType="pubmed">36472284</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C, Torres-Macho J, Velasco-Arribas M, et al. Preexisting hypertension is associated with a greater number of long-term post-COVID symptoms and poor sleep quality: a case-control study. J Hum Hypertens. 2022;36(6):582&#x2013;584. doi:10.1038/s41371-022-00660-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41371-022-00660-6</ArticleId><ArticleId IdType="pmc">PMC8853057</ArticleId><ArticleId IdType="pubmed">35173268</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, Wang SJ. Hypertension and Migraine: time to Revisit the Evidence. Curr Pain Headache Rep. 2021;25(9):58. doi:10.1007/s11916-021-00976-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11916-021-00976-x</ArticleId><ArticleId IdType="pubmed">34269909</ArticleId></ArticleIdList></Reference><Reference><Citation>Laffin LJ, Kaufman HW, Chen Z, et al. Rise in Blood Pressure Observed Among US Adults During the COVID-19 Pandemic. Circulation. 2022;145(3):235&#x2013;237. doi:10.1161/CIRCULATIONAHA.121.057075</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.057075</ArticleId><ArticleId IdType="pmc">PMC8763044</ArticleId><ArticleId IdType="pubmed">34865499</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631. doi:10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen N, Gurdasani D, ME O, et al. Characteristics and impact of Long Covid: findings from an online survey. PLoS One. 2022;17(3):e0264331. doi:10.1371/journal.pone.0264331</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264331</ArticleId><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Kersten J, Baumhardt M, Hartveg P, et al. Long COVID: distinction between Organ Damage and Deconditioning. J Clin Med. 2021;10(17). doi:10.3390/jcm10173782</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10173782</ArticleId><ArticleId IdType="pmc">PMC8432179</ArticleId><ArticleId IdType="pubmed">34501230</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging. 2020;12(7):6049&#x2013;6057. doi:10.18632/aging.103000</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103000</ArticleId><ArticleId IdType="pmc">PMC7185114</ArticleId><ArticleId IdType="pubmed">32267833</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki O, Shibata S. Severe COVID-19 and preexisting hypertension: a matter of age? Hypertens Res. 2022;45(9):1523&#x2013;1525. doi:10.1038/s41440-022-00978-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-022-00978-1</ArticleId><ArticleId IdType="pmc">PMC9283815</ArticleId><ArticleId IdType="pubmed">35840751</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG, Brokstad KA, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27(9):1607&#x2013;1613. doi:10.1038/s41591-021-01433-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen K, Ren S, Heath K, et al. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2022;376:e068414. doi:10.1136/bmj-2021-068414</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068414</ArticleId><ArticleId IdType="pmc">PMC8828141</ArticleId><ArticleId IdType="pubmed">35140117</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty SE, Guo Y, Heath K, et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2021(373):n1098. doi:10.1136/bmj.n1098</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirza H, Noori MAM, Akbar H, et al. Hypertension as an Independent Risk Factor for In-Patient Mortality in Hospitalized COVID-19 Patients: a Multicenter Study. Cureus. 2022;14(7):e26741. doi:10.7759/cureus.26741</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.26741</ArticleId><ArticleId IdType="pmc">PMC9275529</ArticleId><ArticleId IdType="pubmed">35836713</ArticleId></ArticleIdList></Reference><Reference><Citation>Syndrome AM
About Metabolic Syndrome
Available from: https://www.heart.org/en/healthtopics/metabolic-syndrome/about-metabolic-syndrome. Acessed September
26, 2024.</Citation></Reference><Reference><Citation>Pirillo A, Casula M, Olmastroni E, Norata GD, Catapano AL. Global epidemiology of dyslipidaemias. Nat Rev Cardiol. 2021;18(10):689&#x2013;700. doi:10.1038/s41569-021-00541-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-021-00541-4</ArticleId><ArticleId IdType="pubmed">33833450</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoemark DK, Colenso CK, Toelzer C, et al. Molecular Simulations suggest Vitamins, Retinoids and Steroids as Ligands of the Free Fatty Acid Pocket of the SARS-CoV-2 Spike Protein*. Angew Chem Int Ed Engl. 2021;60(13):7098&#x2013;7110. doi:10.1002/anie.202015639</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.202015639</ArticleId><ArticleId IdType="pmc">PMC8013358</ArticleId><ArticleId IdType="pubmed">33469977</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G, Zhang Q, Zhao X, et al. Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study. Lipids Health Dis. 2020;19(1):204. doi:10.1186/s12944-020-01382-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12944-020-01382-9</ArticleId><ArticleId IdType="pmc">PMC7475024</ArticleId><ArticleId IdType="pubmed">32892746</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X, Chen D, Wu L, He G, Ye W. Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection. Clin Chim Acta. 2020;510:105&#x2013;110. doi:10.1016/j.cca.2020.07.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2020.07.015</ArticleId><ArticleId IdType="pmc">PMC7350883</ArticleId><ArticleId IdType="pubmed">32653486</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka S, De Tymowski C, Assadi M, et al. Lipoprotein concentrations over time in the intensive care unit COVID-19 patients: results from the ApoCOVID study. PLoS One. 2020;15(9):e0239573. doi:10.1371/journal.pone.0239573</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0239573</ArticleId><ArticleId IdType="pmc">PMC7514065</ArticleId><ArticleId IdType="pubmed">32970772</ArticleId></ArticleIdList></Reference><Reference><Citation>Souza Junior DR, Silva ARM, Rosa-Fernandes L, et al. HDL proteome remodeling associates with COVID-19 severity. J Clin Lipidol. 2021;15(6):796&#x2013;804. doi:10.1016/j.jacl.2021.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacl.2021.10.005</ArticleId><ArticleId IdType="pmc">PMC8557113</ArticleId><ArticleId IdType="pubmed">34802985</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho KH, Kim JR, Lee IC, Kwon HJ. Native High-Density Lipoproteins (HDL) with Higher Paraoxonase Exerts a Potent Antiviral Effect against SARS-CoV-2 (COVID-19), While Glycated HDL Lost the Antiviral Activity. Antioxidants (Basel). 2021;10(2). doi:10.3390/antiox10020209</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10020209</ArticleId><ArticleId IdType="pmc">PMC7912765</ArticleId><ArticleId IdType="pubmed">33535459</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulminski AM, Barochia AV, Loika Y, et al. The APOE epsilon4 allele is associated with a reduction in FEV1/FVC in women: a cross-sectional analysis of the Long Life Family Study. PLoS One. 2018;13(11):e0206873. doi:10.1371/journal.pone.0206873</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0206873</ArticleId><ArticleId IdType="pmc">PMC6226172</ArticleId><ArticleId IdType="pubmed">30412599</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein MR, Poland GA, Graeber CW. Are certain drugs associated with enhanced mortality in COVID-19? QJM. 2020;113(7):509&#x2013;510. doi:10.1093/qjmed/hcaa103</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcaa103</ArticleId><ArticleId IdType="pmc">PMC7184481</ArticleId><ArticleId IdType="pubmed">32219440</ArticleId></ArticleIdList></Reference><Reference><Citation>Aparisi A, Martin-Fernandez M, Ybarra-Falcon C, et al. Dyslipidemia and Inflammation as Hallmarks of Oxidative Stress in COVID-19: a Follow-Up Study. Int J Mol Sci. 2022;23(23):15350. doi:10.3390/ijms232315350</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232315350</ArticleId><ArticleId IdType="pmc">PMC9736368</ArticleId><ArticleId IdType="pubmed">36499671</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai W, Lund H, Chen Y, et al. Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19. J Clin Lipidol. 2021;15(5):724&#x2013;731. doi:10.1016/j.jacl.2021.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacl.2021.08.002</ArticleId><ArticleId IdType="pmc">PMC8353976</ArticleId><ArticleId IdType="pubmed">34470719</ArticleId></ArticleIdList></Reference><Reference><Citation>Almas T, Malik J, Alsubai AK, et al. Effect of COVID-19 on lipid profile parameters and its correlation with acute phase reactants: a single-center retrospective analysis. Ann Med Surg (Lond). 2022;78:103856. doi:10.1016/j.amsu.2022.103856</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2022.103856</ArticleId><ArticleId IdType="pmc">PMC9134795</ArticleId><ArticleId IdType="pubmed">35637852</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahat RK, Rathore V, Singh N, et al. Lipid profile as an indicator of COVID-19 severity: a systematic review and meta-analysis. Clin Nutr ESPEN. 2021;45:91&#x2013;101. doi:10.1016/j.clnesp.2021.07.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnesp.2021.07.023</ArticleId><ArticleId IdType="pmc">PMC8325550</ArticleId><ArticleId IdType="pubmed">34620375</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei X, Zeng W, Su J, et al. Hypolipidemia is associated with the severity of COVID-19. J Clin Lipidol. 2020;14(3):297&#x2013;304. doi:10.1016/j.jacl.2020.04.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacl.2020.04.008</ArticleId><ArticleId IdType="pmc">PMC7192140</ArticleId><ArticleId IdType="pubmed">32430154</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Lenardo MJ, Baltimore D. 30 Years of NF-kappaB: a Blossoming of Relevance to Human Pathobiology. Cell. 2017;168(1&#x2013;2):37&#x2013;57. doi:10.1016/j.cell.2016.12.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.12.012</ArticleId><ArticleId IdType="pmc">PMC5268070</ArticleId><ArticleId IdType="pubmed">28086098</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Saiagh W, Tiun S, Al-Saffar A, Awang S, Al-Khaleefa AS, Pappalardo F. Word sense disambiguation using hybrid swarm intelligence approach. PLoS One. 2018;13(12):e0208695. doi:10.1371/journal.pone.0208695</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0208695</ArticleId><ArticleId IdType="pmc">PMC6301655</ArticleId><ArticleId IdType="pubmed">30571777</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu T, Yang X, Wang J, et al. Obesity-induced elevated palmitic acid promotes inflammation and glucose metabolism disorders through GPRs/NF-kappaB/KLF7 pathway. Nutr Diabetes. 2022;12(1):23. doi:10.1038/s41387-022-00202-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41387-022-00202-6</ArticleId><ArticleId IdType="pmc">PMC9021212</ArticleId><ArticleId IdType="pubmed">35443706</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori J, Zhang L, Oudit GY, Lopaschuk GD. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure. J Mol Cell Cardiol. 2013;63:98&#x2013;106. doi:10.1016/j.yjmcc.2013.07.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2013.07.010</ArticleId><ArticleId IdType="pubmed">23886814</ArticleId></ArticleIdList></Reference><Reference><Citation>Butts B, Gary RA, Dunbar SB, Butler J. Methylation of Apoptosis-Associated Speck-Like Protein With a Caspase Recruitment Domain and Outcomes in Heart Failure. J Card Fail. 2016;22(5):340&#x2013;346. doi:10.1016/j.cardfail.2015.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardfail.2015.12.004</ArticleId><ArticleId IdType="pmc">PMC4861674</ArticleId><ArticleId IdType="pubmed">26700661</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Luo W, Yu T, et al. Corynoline protects ang II-induced hypertensive heart failure by increasing PPARalpha and Inhibiting NF-kappaB pathway. Biomed Pharmacother. 2022;150:113075. doi:10.1016/j.biopha.2022.113075</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2022.113075</ArticleId><ArticleId IdType="pubmed">35658238</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriwijitkamol A, Christ-Roberts C, Berria R, et al. Reduced skeletal muscle inhibitor of kappaB beta content is associated with insulin resistance in subjects with type 2 diabetes: reversal by exercise training. Diabetes. 2006;55(3):760&#x2013;767. doi:10.2337/diabetes.55.03.06.db05-0677</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diabetes.55.03.06.db05-0677</ArticleId><ArticleId IdType="pubmed">16505240</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Fu Y, Wei C, Chen Y, Ma S, Xu W. The expression of GPR109A, NF-kB and IL-1beta in peripheral blood leukocytes from patients with type 2 diabetes. Ann Clin Lab Sci. 2014;44(4):443&#x2013;448.</Citation><ArticleIdList><ArticleId IdType="pubmed">25361930</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyerovich K, Ortis F, Cardozo AK. The non-canonical NF-kappaB pathway and its contribution to beta-cell failure in diabetes. J Mol Endocrinol. 2018;61(2):F1&#x2013;F6. doi:10.1530/JME-16-0183</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/JME-16-0183</ArticleId><ArticleId IdType="pubmed">29728424</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L, Han J, Yuan R, Xue L, Pang W. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-kappaB pathway. Biol Res. 2018;51(1):9. doi:10.1186/s40659-018-0157-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40659-018-0157-8</ArticleId><ArticleId IdType="pmc">PMC5878418</ArticleId><ArticleId IdType="pubmed">29604956</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaidt MM, Ebert TS, Chauhan D, et al. The DNA Inflammasome in Human Myeloid Cells Is Initiated by a STING-Cell Death Program Upstream of NLRP3. Cell. 2017;171(5):1110&#x2013;1124e1118. doi:10.1016/j.cell.2017.09.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.09.039</ArticleId><ArticleId IdType="pmc">PMC5901709</ArticleId><ArticleId IdType="pubmed">29033128</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai J, Liu F. The cGAS-cGAMP-STING Pathway: a Molecular Link Between Immunity and Metabolism. Diabetes. 2019;68(6):1099&#x2013;1108. doi:10.2337/dbi18-0052</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dbi18-0052</ArticleId><ArticleId IdType="pmc">PMC6610018</ArticleId><ArticleId IdType="pubmed">31109939</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamann L, Szwed M, Mossakowska M, Chudek J, Puzianowska-Kuznicka M. First evidence for STING SNP R293Q being protective regarding obesity-associated cardiovascular disease in age-advanced subjects - a cohort study. Immun Ageing. 2020;17:7. doi:10.1186/s12979-020-00176-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-020-00176-y</ArticleId><ArticleId IdType="pmc">PMC7071752</ArticleId><ArticleId IdType="pubmed">32190093</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu HQ, Qiao JT, Liu FQ, et al. The STING-IRF3 pathway is involved in lipotoxic injury of pancreatic beta cells in type 2 diabetes. Mol Cell Endocrinol. 2020;518:110890. doi:10.1016/j.mce.2020.110890</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2020.110890</ArticleId><ArticleId IdType="pubmed">32781250</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Y, Luo W, Zhang L, et al. STING-IRF3 Triggers Endothelial Inflammation in Response to Free Fatty Acid-Induced Mitochondrial Damage in Diet-Induced Obesity. Arterioscler Thromb Vasc Biol. 2017;37(5):920&#x2013;929. doi:10.1161/ATVBAHA.117.309017</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.117.309017</ArticleId><ArticleId IdType="pmc">PMC5408305</ArticleId><ArticleId IdType="pubmed">28302626</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M, Rhee I. Cytokine Signaling in Tumor Progression. Immune Netw. 2017;17(4):214&#x2013;227. doi:10.4110/in.2017.17.4.214</Citation><ArticleIdList><ArticleId IdType="doi">10.4110/in.2017.17.4.214</ArticleId><ArticleId IdType="pmc">PMC5577299</ArticleId><ArticleId IdType="pubmed">28860951</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik VS, Willett WC, Hu FB. Global obesity: trends, risk factors and policy implications. Nat Rev Endocrinol. 2013;9(1):13&#x2013;27. doi:10.1038/nrendo.2012.199</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2012.199</ArticleId><ArticleId IdType="pubmed">23165161</ArticleId></ArticleIdList></Reference><Reference><Citation>Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab. 2008;93(11):S9&#x2013;30. doi:10.1210/jc.2008-1595</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2008-1595</ArticleId><ArticleId IdType="pubmed">18987276</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zhang X, Xie X, et al. Obesity and metabolic syndrome related macrophage promotes PD-L1 expression in TNBC through IL6/JAK/STAT pathway and can be reversed by telmisartan. Cancer Biol Ther. 2020;21(12):1179&#x2013;1190. doi:10.1080/15384047.2020.1838032</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15384047.2020.1838032</ArticleId><ArticleId IdType="pmc">PMC7722790</ArticleId><ArticleId IdType="pubmed">33218268</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian S, Zhao H, Song H Shared signaling pathways and targeted therapy by natural bioactive compounds for obesity and type 2 diabetes. Crit Rev Food Sci Nutr. 2022: 1&#x2013;18.doi:10.1080/10408398.2022.2148090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2022.2148090</ArticleId><ArticleId IdType="pubmed">36397728</ArticleId></ArticleIdList></Reference><Reference><Citation>Jhun J, Woo JS, Lee SH, et al. GRIM19 Impedes Obesity by Regulating Inflammatory White Fat Browning and Promoting Th17/Treg Balance. Cells. 2021;10(1):162. doi:10.3390/cells10010162</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10010162</ArticleId><ArticleId IdType="pmc">PMC7829987</ArticleId><ArticleId IdType="pubmed">33467683</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M, Mok MT, Sun H, et al. The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis. Oncogene. 2017;36(29):4135&#x2013;4149. doi:10.1038/onc.2017.38</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2017.38</ArticleId><ArticleId IdType="pubmed">28319060</ArticleId></ArticleIdList></Reference><Reference><Citation>Moshapa FT, Riches-Suman K, Palmer TM. Therapeutic Targeting of the Proinflammatory IL-6-JAK/STAT Signalling Pathways Responsible for Vascular Restenosis in Type 2 Diabetes Mellitus. Cardiology Research and Practice. 2019;2019:9846312. doi:10.1155/2019/9846312</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/9846312</ArticleId><ArticleId IdType="pmc">PMC6334365</ArticleId><ArticleId IdType="pubmed">30719343</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D, Liu Y, Chen J, et al. JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes. Eur J Pharmacol. 2021;902:174121. doi:10.1016/j.ejphar.2021.174121</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2021.174121</ArticleId><ArticleId IdType="pubmed">33901462</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Yuan Z, Pavel MA, et al. The role of high cholesterol in age-related COVID19 lethality. bioRxiv. 2021. doi:10.1101/2020.05.09.086249</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.09.086249</ArticleId></ArticleIdList></Reference><Reference><Citation>WK OH, Saso W. Multidrug treatment with nelfinavir and cepharanthine against COVID-19. BioRxiv.</Citation></Reference><Reference><Citation>Tikoo K, Patel G, Kumar S, et al. Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications. Biochem Pharmacol. 2015;93(3):343&#x2013;351. doi:10.1016/j.bcp.2014.11.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2014.11.013</ArticleId><ArticleId IdType="pubmed">25482567</ArticleId></ArticleIdList></Reference><Reference><Citation>Semenzato L, Botton J, Drouin J, et al. Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people. Lancet Reg Health Eur. 2021;8:100158. doi:10.1016/j.lanepe.2021.100158</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100158</ArticleId><ArticleId IdType="pmc">PMC8282330</ArticleId><ArticleId IdType="pubmed">34308411</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancusi C, Grassi G, Borghi C, et al. Determinants of healing among patients with coronavirus disease 2019: the results of the SARS-RAS study of the Italian Society of Hypertension. J Hypertens. 2021;39(2):376&#x2013;380. doi:10.1097/HJH.0000000000002666</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HJH.0000000000002666</ArticleId><ArticleId IdType="pubmed">33186327</ArticleId></ArticleIdList></Reference><Reference><Citation>Iaccarino G, Grassi G, Borghi C, et al. Age and Multimorbidity Predict Death Among COVID-19 Patients: results of the SARS-RAS Study of the Italian Society of Hypertension. Hypertension. 2020;76(2):366&#x2013;372. doi:10.1161/HYPERTENSIONAHA.120.15324</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.15324</ArticleId><ArticleId IdType="pubmed">32564693</ArticleId></ArticleIdList></Reference><Reference><Citation>RISk C, Treatments C. RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies. Vascul Pharmacol. 2020;135:106805. doi:10.1016/j.vph.2020.106805</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2020.106805</ArticleId><ArticleId IdType="pmc">PMC7521934</ArticleId><ArticleId IdType="pubmed">32992048</ArticleId></ArticleIdList></Reference><Reference><Citation>Barochiner J, Martinez R. Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: a systematic review and meta-analysis. J Clin Pharm Ther. 2020;45(6):1244&#x2013;1252. doi:10.1111/jcpt.13246</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpt.13246</ArticleId><ArticleId IdType="pmc">PMC7436708</ArticleId><ArticleId IdType="pubmed">32767823</ArticleId></ArticleIdList></Reference><Reference><Citation>Flacco ME, Acuti Martellucci C, Bravi F, et al. Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis. Heart. 2020;106(19):1519&#x2013;1524. doi:10.1136/heartjnl-2020-317336</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2020-317336</ArticleId><ArticleId IdType="pmc">PMC7371482</ArticleId><ArticleId IdType="pubmed">32611676</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirola CJ, Sookoian S. Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: a Meta-analysis. J Infect. 2020;81(2):276&#x2013;281. doi:10.1016/j.jinf.2020.05.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.05.052</ArticleId><ArticleId IdType="pmc">PMC7255761</ArticleId><ArticleId IdType="pubmed">32474043</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X, Zhu Y, Hong Y. Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: a Meta-Analysis. Hypertension. 2020;76(2):e13&#x2013;e14. doi:10.1161/HYPERTENSIONAHA.120.15572</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.15572</ArticleId><ArticleId IdType="pubmed">32458694</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Yu J, Pan LY, Jiang HY. ACEI/ARB use and risk of infection or severity or mortality of COVID-19: a systematic review and meta-analysis. Pharmacol Res. 2020;158:104927. doi:10.1016/j.phrs.2020.104927</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.104927</ArticleId><ArticleId IdType="pmc">PMC7227582</ArticleId><ArticleId IdType="pubmed">32422341</ArticleId></ArticleIdList></Reference><Reference><Citation>medRxiv. Available from: https://www.medrxiv.org/content/10. Acessed September
26, 2024.</Citation></Reference><Reference><Citation>Semenzato L, Botton J, Drouin J, et al. Antihypertensive Drugs and COVID-19 Risk: a Cohort Study of 2 Million Hypertensive Patients. Hypertension. 2021;77(3):833&#x2013;842. doi:10.1161/HYPERTENSIONAHA.120.16314</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.16314</ArticleId><ArticleId IdType="pmc">PMC7884243</ArticleId><ArticleId IdType="pubmed">33423528</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19. N Engl J Med. 2020;382(25):2431&#x2013;2440. doi:10.1056/NEJMoa2006923</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2006923</ArticleId><ArticleId IdType="pmc">PMC7206933</ArticleId><ArticleId IdType="pubmed">32356627</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds HR, Adhikari S, Pulgarin C, et al. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19. N Engl J Med. 2020;382(25):2441&#x2013;2448. doi:10.1056/NEJMoa2008975</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2008975</ArticleId><ArticleId IdType="pmc">PMC7206932</ArticleId><ArticleId IdType="pubmed">32356628</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramante CT, Ingraham NE, Murray TA, et al. Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis. Lancet Healthy Longev. 2021;2(1):e34&#x2013;e41. doi:10.1016/S2666-7568(20)30033-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-7568(20)30033-7</ArticleId><ArticleId IdType="pmc">PMC7832552</ArticleId><ArticleId IdType="pubmed">33521772</ArticleId></ArticleIdList></Reference><Reference><Citation>Khunti K, Knighton P, Zaccardi F, et al. Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England. Lancet Diabetes Endocrinol. 2021;9(5):293&#x2013;303. doi:10.1016/S2213-8587(21)00050-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(21)00050-4</ArticleId><ArticleId IdType="pmc">PMC8009618</ArticleId><ArticleId IdType="pubmed">33798464</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng X, Liu YM, Li H, et al. Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab. 2020;32(4):537&#x2013;547e533. doi:10.1016/j.cmet.2020.08.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.08.013</ArticleId><ArticleId IdType="pmc">PMC7439986</ArticleId><ArticleId IdType="pubmed">32861268</ArticleId></ArticleIdList></Reference><Reference><Citation>Valencia I, Peiro C, Lorenzo O, Sanchez-Ferrer CF, Eckel J, Romacho T. DPP4 and ACE2 in Diabetes and COVID-19: therapeutic Targets for Cardiovascular Complications? Front Pharmacol. 2020;11(1161). doi:10.3389/fphar.2020.01161</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.01161</ArticleId><ArticleId IdType="pmc">PMC7426477</ArticleId><ArticleId IdType="pubmed">32848769</ArticleId></ArticleIdList></Reference><Reference><Citation>Wargny M, Potier L, Gourdy P, et al. investigators C. Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study. Diabetologia. 2021;64(4):778&#x2013;794. doi:10.1007/s00125-020-05351-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-020-05351-w</ArticleId><ArticleId IdType="pmc">PMC7890396</ArticleId><ArticleId IdType="pubmed">33599800</ArticleId></ArticleIdList></Reference><Reference><Citation>Strollo R, Maddaloni E, Dauriz M, Pedone C, Buzzetti R, Pozzilli P. Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths. Diabetes Res Clin Pract. 2021(171):108444. doi:10.1016/j.diabres.2020.108444</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2020.108444</ArticleId><ArticleId IdType="pmc">PMC7492144</ArticleId><ArticleId IdType="pubmed">32946854</ArticleId></ArticleIdList></Reference><Reference><Citation>AstraZeneca. Update on the DARE-19 Phase III trial for Farxiga in COVID-19
Available from: https://www.astrazeneca.com/media-centre/press-releases/2021/update-on-farxiga-covid-19-dare-19-phase-iii-trial.html. Acessed September
26, 2024.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>